Literature DB >> 9529383

Dissection of de novo membrane insertion activities of internal transmembrane segments of ATP-binding-cassette transporters: toward understanding topological rules for membrane assembly of polytopic membrane proteins.

J T Zhang1, M Chen, E Han, C Wang.   

Abstract

The membrane assembly of polytopic membrane proteins is a complicated process. Using Chinese hamster P-glycoprotein (Pgp) as a model protein, we investigated this process previously and found that Pgp expresses more than one topology. One of the variations occurs at the transmembrane (TM) domain including TM3 and TM4: TM4 inserts into membranes in an N(in)-C(out) rather than the predicted N(out)-C(in) orientation, and TM3 is in cytoplasm rather than the predicted N(in)-C(out) orientation in the membrane. It is possible that TM4 has a strong activity to initiate the N(in)-C(out) membrane insertion, leaving TM3 out of the membrane. Here, we tested this hypothesis by expressing TM3 and TM4 in isolated conditions. Our results show that TM3 of Pgp does not have de novo N(in)-C(out) membrane insertion activity whereas TM4 initiates the N(in)-C(out) membrane insertion regardless of the presence of TM3. In contrast, TM3 and TM4 of another polytopic membrane protein, cystic fibrosis transmembrane conductance regulator (CFTR), have a similar level of de novo Nin-Cout membrane insertion activity and TM4 of CFTR functions only as a stop-transfer sequence in the presence of TM3. Based on these findings, we propose that 1) the membrane insertion of TM3 and TM4 of Pgp does not follow the sequential model, which predicts that TM3 initiates N(in)-C(out) membrane insertion whereas TM4 stops the insertion event; and 2) "leaving one TM segment out of the membrane" may be an important folding mechanism for polytopic membrane proteins, and it is regulated by the N(in)-C(out) membrane insertion activities of the TM segments.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529383      PMCID: PMC25312          DOI: 10.1091/mbc.9.4.853

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  38 in total

1.  A protein-conducting channel in the endoplasmic reticulum.

Authors:  S M Simon; G Blobel
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

2.  Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3.

Authors:  C Kast; V Canfield; R Levenson; P Gros
Journal:  Biochemistry       Date:  1995-04-04       Impact factor: 3.162

3.  Insertion of a multispanning membrane protein occurs sequentially and requires only one signal sequence.

Authors:  H P Wessels; M Spiess
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

4.  Topogenic signals in integral membrane proteins.

Authors:  G von Heijne; Y Gavel
Journal:  Eur J Biochem       Date:  1988-07-01

5.  Study of membrane orientation and glycosylated extracellular loops of mouse P-glycoprotein by in vitro translation.

Authors:  J T Zhang; V Ling
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

6.  Membrane insertion, processing, and topology of cystic fibrosis transmembrane conductance regulator (CFTR) in microsomal membranes.

Authors:  M Chen; J T Zhang
Journal:  Mol Membr Biol       Date:  1996 Jan-Mar       Impact factor: 2.857

7.  An amphipathic sequence determinant of membrane protein topology.

Authors:  L Seligman; C Manoil
Journal:  J Biol Chem       Date:  1994-08-05       Impact factor: 5.157

8.  Topological determinants of internal transmembrane segments in P-glycoprotein sequences.

Authors:  J T Zhang; C H Lee; M Duthie; V Ling
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

9.  Multiple topogenic sequences in bovine opsin.

Authors:  Y Audigier; M Friedlander; G Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

10.  Transmembrane orientation and topogenesis of the third and fourth membrane-spanning regions of human P-glycoprotein (MDR1).

Authors:  W R Skach; V R Lingappa
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

View more
  8 in total

Review 1.  Membrane topology and insertion of membrane proteins: search for topogenic signals.

Authors:  M van Geest; J S Lolkema
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

2.  Determinant of the extracellular location of the N-terminus of human multidrug-resistance-associated protein.

Authors:  J T Zhang
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

Review 3.  Understanding the biogenesis of polytopic integral membrane proteins.

Authors:  R J Turner
Journal:  J Membr Biol       Date:  2003-04-01       Impact factor: 1.843

4.  p97 functions as an auxiliary factor to facilitate TM domain extraction during CFTR ER-associated degradation.

Authors:  Eric J Carlson; David Pitonzo; William R Skach
Journal:  EMBO J       Date:  2006-09-14       Impact factor: 11.598

Review 5.  Biogenesis of CFTR and other polytopic membrane proteins: new roles for the ribosome-translocon complex.

Authors:  H Sadlish; W R Skach
Journal:  J Membr Biol       Date:  2004-12       Impact factor: 1.843

6.  ACAT1 and ACAT2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane.

Authors:  C W Joyce; G S Shelness; M A Davis; R G Lee; K Skinner; R A Anderson; L L Rudel
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

7.  Different roles of TM5, TM6, and ECL3 in the oligomerization and function of human ABCG2.

Authors:  Wei Mo; Jing Qi; Jian-Ting Zhang
Journal:  Biochemistry       Date:  2012-04-19       Impact factor: 3.162

8.  A minimal helical-hairpin motif provides molecular-level insights into misfolding and pharmacological rescue of CFTR.

Authors:  Georg Krainer; Antoine Treff; Andreas Hartmann; Tracy A Stone; Mathias Schenkel; Sandro Keller; Charles M Deber; Michael Schlierf
Journal:  Commun Biol       Date:  2018-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.